Pan 2022z
The third inactivated vaccine booster dramatically enhanced SARS-CoV-2 antibody responses and did not influence the profile of prothrombotic antibody
  1. Study Type
  2. Observational
  1. Study Aim
  2. Diagnostic/Prognostic
  3. Prevention
  4. Mechanism
  1. Study Design
  2. Case series/Case control/Cohort
  1. Intervention Assignment
  2. Not Applicable
References (1)
Keebayoon 2022b
Spike-specific humoral and cellular immune responses after COVID-19 mRNA vaccination in patients with cirrhosis
  1. Study Type
  2. Observational
  1. Study Aim
  2. Diagnostic/Prognostic
  3. Prevention
  4. Mechanism
  1. Study Design
  2. Case series/Case control/Cohort
  1. Intervention Assignment
  2. Not Applicable
References (1)
Monroe 2022c
Longitudinal antibody titer, avidity, and neutralizing responses after SARS-CoV-2 infection
  1. Study Type
  2. Observational
  1. Study Aim
  2. Diagnostic/Prognostic
  3. Mechanism
  1. Study Design
  2. Case series/Case control/Cohort
  1. Intervention Assignment
  2. Not Applicable
References (1)
Basheer 2022d
Regen-COV-2 Antibody Cocktail Mediated Clearance of SARS-COV-2 in an Immunocompromised Patient
  1. Study Type
  2. Observational
  1. Study Aim
  2. Diagnostic/Prognostic
  1. Study Design
  2. Case Report
  1. Intervention Assignment
  2. Not Applicable
References (1)
Schwab 2022l
Autopsy-based histopathological characterization of myocarditis after anti-SARS-CoV-2-vaccination
  1. Study Type
  2. Observational
  1. Study Aim
  2. Diagnostic/Prognostic
  3. Prevention
  1. Study Design
  2. Other
  1. Intervention Assignment
  2. Not Applicable
References (1)
Du 2022v
Sensitivity Enhanced Plasmonic Biosensor Using Bi2Se3-Graphene Heterostructures: a Theoretical Analysis
  1. Study Type
  2. Observational
  1. Study Aim
  2. Diagnostic/Prognostic
  1. Study Design
  2. Other
  1. Intervention Assignment
  2. Not Applicable
References (1)
Siman-Tov 2022
Elevated Serum Amyloid A Levels Contribute to Increased Platelet Adhesion in COVID-19 Patients
  1. Study Type
  2. Observational
  1. Study Aim
  2. Diagnostic/Prognostic
  3. Mechanism
  1. Study Design
  2. Case series/Case control/Cohort
  1. Intervention Assignment
  2. Not Applicable
References (1)
Speletas 2022a
The rs1883832 Polymorphism (CD40-1C>T) Affects the Intensity of IgA Responses after BNT162b2 Vaccination
  1. Study Type
  2. Observational
  1. Study Aim
  2. Diagnostic/Prognostic
  3. Prevention
  4. Mechanism
  1. Study Design
  2. Case series/Case control/Cohort
  1. Intervention Assignment
  2. Not Applicable
References (1)
Decarreaux 2022b
Eight Months of Serological Follow-Up of Anti-SARS-CoV-2 Antibodies in France: a Study among an Adult Population
  1. Study Type
  2. Observational
  1. Study Aim
  2. Diagnostic/Prognostic
  3. Prevention
  1. Study Design
  2. Case series/Case control/Cohort
  1. Intervention Assignment
  2. Not Applicable
References (1)
Bílek 2022
Antiviral activity of amiodarone in SARS-CoV-2 disease
  1. Study Type
  2. Observational
  1. Study Aim
  2. Diagnostic/Prognostic
  1. Study Design
  2. Other
  1. Intervention Assignment
  2. Not Applicable
References (1)
AmeliMojarad 2022
Simvastatin Therapy Increased miR-150-5p
Expression in the Patients with Type 2 Diabetes and COVID-19
  1. Study Type
  2. Observational
  1. Study Aim
  1. Study Design
  2. Case series/Case control/Cohort
  1. Intervention Assignment
  2. Not Applicable
References (1)
Zhao 2022cr
Detection of SARS-CoV-2 antibodies in serum and dried blood spot samples of vaccinated individuals using a sensitive homogeneous proximity extension assay
  1. Study Type
  2. Observational
  1. Study Aim
  2. Diagnostic/Prognostic
  1. Study Design
  2. Other
  1. Intervention Assignment
  2. Not Applicable
References (1)
Quiroga 2022g
Humoral response after the fourth dose of the SARS-CoV-2 vaccine in the CKD spectrum: a prespecified analysis of the SENCOVAC study
  1. Study Type
  2. Observational
  1. Study Aim
  2. Prevention
  1. Study Design
  2. Case series/Case control/Cohort
  1. Intervention Assignment
  2. Not Applicable
References (1)
Wagatsuma 2022c
Assessing the Pre-Vaccination Anti-SARS-CoV-2 IgG Seroprevalence among Residents and Staff in Nursing Home in Niigata, Japan, November 2020
  1. Study Type
  2. Observational
  1. Study Aim
  2. Diagnostic/Prognostic
  3. Epidemiology
  1. Study Design
  2. Cross-sectional
  1. Intervention Assignment
  2. Not Applicable
References (1)
Lawton 2022a
Seroprevalence of SARS-CoV-2 in 1186 Equids Presented to a Veterinary Medical Teaching Hospital in California from 2020 to 2022
  1. Study Type
  2. Observational
  1. Study Aim
  2. Diagnostic/Prognostic
  1. Study Design
  2. Other
  1. Intervention Assignment
  2. Not Applicable
References (1)
0 Selected
ExportClear